Read the full stored bill text
PRINTER'S NO. 1465
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE RESOLUTION
No. 230
Session of
2026
INTRODUCED BY FONTANA, HAYWOOD, HUGHES, MASTRIANO, TARTAGLIONE,
COSTA, SANTARSIERO, KANE, CAPPELLETTI, PISCIOTTANO, PHILLIPS-
HILL, J. WARD AND VOGEL, FEBRUARY 27, 2026
REFERRED TO RULES AND EXECUTIVE NOMINATIONS, FEBRUARY 27, 2026
A RESOLUTION
Designating March 25, 2026, as "Autoimmune Hemolytic Anemia
Awareness Day" in Pennsylvania.
WHEREAS, Autoimmune hemolytic anemia (AIHA) is a rare form of
anemia that is diagnosed in only about 1 to 3 people per
100,000; and
WHEREAS, The condition occurs when a person's immune system
attacks and destroys their red blood cells, which is responsible
for carrying oxygen throughout the body, faster than a person's
bone marrow can make them; and
WHEREAS, The condition causes symptoms such as fatigue,
dizziness, feeling short of breath or having a rapid heartbeat;
and
WHEREAS, AIHA is divided into two groups: Primary and
Secondary; and
WHEREAS, Primary AIHA is not caused by another condition; and
WHEREAS, Certain conditions like Lupus, rheumatoid arthritis,
non-Hodgkin lymphoma, hepatitis and HIV can cause secondary
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
AIHA; and
WHEREAS, The temperature at which damage occurs determines
the AIHA type which can be either warm or cold; and
WHEREAS, Medical professionals often do not recognize the
disease which could create delays in care; and
WHEREAS, AIHA may have complications, including serious
infections, such as pneumonia and heart disease; and
WHEREAS, If left untreated, AIHA can lead to potentially
life-threatening complications; and
WHEREAS, There is no cure for AIHA; and
WHEREAS, However, research with drugs currently in clinical
trial have the potential to improve outcomes for patients;
therefore be it
RESOLVED, That the Senate designate March 25, 2026, as
"Autoimmune Hemolytic Anemia Awareness Day" in Pennsylvania.
20260SR0230PN1465 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15